Home > Insider Trading > Filing (0001209191-20-014230)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
353569	Quidel Corp	QDEL	In Vitro & In Vivo Diagnostic Substances (2835)	942573850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1655234	Keith Edward Russell	9975 Summers Ridge Road San Diego CA 92121	Svp, Business Development	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-02-26	12,601	$15.40	29,791	No	4	M	Direct
Common Stock	Disposition	2020-02-26	12,601	$79.58	17,190	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option	Disposition	2020-02-26	12,601	$0.00	12,601	$15.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2026-02-10	No	4	M	Direct

Footnotes

The weighted average sale price for these transactions was $79.580661 per share, with a range of $77.93 to $80.10. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
17,596 shares vested on February 10, 2018; 8,798 shares vested on February 10, 2019; and 8,798 shares vested on February 10, 2020.